BDBM14777
 | 4 | 88 | 0 | 1 | 0 | 0 | 0 | 0 | - 3',5'-cyclic phosphodiesterase
- Acetylcholinesterase and butyrylcholinesterase (AChE and BChE)
- Bile salt export pump
- Calcium channel (Type L)
- Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1A
- Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1B
- Canalicular multispecific organic anion transporter 1
- Canalicular multispecific organic anion transporter 2
- Heart phosphodiesterase
- Homo sapiens phosphodiesterase 2A (PDE2A)
- Multidrug resistance-associated protein 4
- Phosphodiesterase 1
- Phosphodiesterase 11A
- Phosphodiesterase 11A (PDE11A)
- Phosphodiesterase 3
- Phosphodiesterase 3 and 5 (PDE3 and PDE5)
- Phosphodiesterase 4
- Phosphodiesterase 4 and 5 (PDE4 and PDE5)
- Phosphodiesterase 5
- Phosphodiesterase 5A
- Phosphodiesterase 6
- Phosphodiesterase 7
- Phosphodiesterase 8
- Phosphodiesterase 9A
- Phosphodiesterase Type 10 (PDE10A)
- Phosphodiesterase Type 11 (PDE11A)
- Phosphodiesterase Type 2 (PDE2A)
- Phosphodiesterase Type 3 (PDE3B)
- Phosphodiesterase Type 4 (PDE4B)
- Phosphodiesterase Type 4 (PDE4D)
- Phosphodiesterase Type 5 (PDE5A)
- Phosphodiesterase Type 7 (PDE7B)
- Phosphodiesterase Type 9 (PDE9A)
- Potassium voltage-gated channel subfamily H member 2
- Sodium channel protein type 5 subunit alpha
- Voltage-gated potassium channel beta subunit Mink/subunit Kv7.1
- cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A
- cAMP-specific 3',5'-cyclic phosphodiesterase 4B
- cGMP-inhibited 3',5'-cyclic phosphodiesterase B
- cGMP-specific 3',5'-cyclic phosphodiesterase
| - (2R,8R)-2-(2H-1,3-benzodioxol-5-yl)-6-methyl-3,6,17-triazatetracyclo[8.7.0.0^{3,8}.0^{11,16}]heptadeca-1(10),11(16),12,14-tetraene-4,7-dione
- (6R,12aR)-6-(1,3-benzodioxol-5-yl)-2-methyl-2,3,6,7,12,12a-hexahydropyrazino[1,2,1,6]pyrido[3,4-b]indole-1,4-dione
- CHEMBL779
- Cialis
- GF 196960
- Tadalafil
|
BDBM50035131
 | 86 | 5 | 2 | 0 | 0 | 0 | 0 | 0 | - 3-beta-hydroxysteroid-delta(8),delta(7)-isomerase
- D(1A) dopamine receptor
- D(2) dopamine receptor
- Mu-type opioid receptor
- Muscarinic acetylcholine receptor M1
- Muscarinic acetylcholine receptor M2
- Sigma non-opioid intracellular receptor 1
- Sigma-1 receptor
| - (+)-(6R,11S)-6,11-dimethyl-3-(3-methyl-but-2-enyl)-1,2,3,4,5,6-hexahydro-2,6-methano-benzo[d]azocin-8-ol
- (-)-PENTAZOCINE
- (1S,9S,13S)-1,13-dimethyl-10-(3-methylbut-2-enyl)-10-azatricyclo[7.3.1.0~2,7~]trideca-2,4,6-trien-4-ol
- (2R,6R,11R)-6,11-Dimethyl-3-(3-methyl-but-2-enyl)-1,2,3,4,5,6-hexahydro-2,6-methano-benzo[d]azocin-8-ol
- (2R,6R,11S)-6,11-dimethyl-3-(3-methyl-but-2-enyl)-1,2,3,4,5,6-hexahydro-2,6-methano-benzo[d]azocin-8-ol
- (2S,3R,6S,11S)-6,11-Dimethyl-3-(3-methyl-but-2-enyl)-1,2,3,4,5,6-hexahydro-2,6-methano-benzo[d]azocin-8-ol
- (2S,6S,11S)-6,11-Dimethyl-3-(3-methyl-but-2-enyl)-1,2,3,4,5,6-hexahydro-2,6-methano-benzo[d]azocin-8-ol
- (6R,11S)-6,11-Dimethyl-3-(3-methyl-but-2-enyl)-1,2,3,4,5,6-hexahydro-2,6-methano-benzo[d]azocin-8-ol
- 6,11-Dimethyl-3-(3-methyl-but-2-enyl)-1,2,3,4,5,6-hexahydro-2,6-ethano-benzo[d]azocin-8-ol(+)-pentazocine
- 6,11-Dimethyl-3-(3-methyl-but-2-enyl)-1,2,3,4,5,6-hexahydro-2,6-methano-benzo[d]azocin-8-ol
- 6,11-Dimethyl-3-(3-methyl-but-2-enyl)-1,2,3,4,5,6-hexahydro-2,6-methano-benzo[d]azocin-8-ol ((+)-pentazocine)
- 6,11-Dimethyl-3-(3-methyl-but-2-enyl)-1,2,3,4,5,6-hexahydro-2,6-methano-benzo[d]azocin-8-ol anion
- 6,11-Dimethyl-3-(3-methyl-but-2-enyl)-1,2,3,4,5,6-hexahydro-2,6-methano-benzo[d]azocin-8-ol((+)pentazocine)
- CHEMBL60542
|